Vicplas International Faces Decline in Revenue and Leadership Changes
Vicplas International Faces Decline in Revenue and Leadership Changes
Vicplas International Ltd, a company incorporated in Singapore, recently responded to inquiries from the Securities Investors Association (Singapore) about their Annual Report 2024 and the upcoming Annual General Meeting (AGM). The company reported a significant decline in revenue and profitability for the financial year ended 31 July 2024, primarily due to a downturn in its medical devices segment.
Key Financial Highlights
For FY2024, the group’s revenue was \$102.4 million, a 20.8% decrease from the previous year. The company recorded a loss of \$1.36 million, contrasting with a profit of \$4.2 million the prior year. The medical devices segment saw a 30.3% revenue drop to \$63.1 million and posted a loss of \$4.2 million, down from a \$3.4 million profit in FY2023. This decline was largely attributed to reduced post-pandemic inventory levels by customers and increased operating costs related to plant expansions in Changzhou and Mexico.
Mexico Plant Developments
The new plant in Mexico is nearing completion, with production lines being validated and infrastructure almost finished. The plant is awaiting its final ISO13485 certification and is expected to contribute to the Group’s revenue in the second half of FY2025. The company has invested heavily in this facility, with \$21,544,000 recorded as segment assets in Mexico.
Geopolitical Concerns
Vicplas is assessing the risk of potential tariffs on exports to the United States, which could impact the profitability of the Mexico plant and the group’s overall supply chain strategy. The medical devices segment has established a multi-country manufacturing footprint to mitigate such risks but acknowledges difficulty in fully assessing the potential impact of new tariffs.
Leadership and Board Changes
The company announced that Mr. Ng Cher Yan will retire at the upcoming AGM, and Mr. Yeo Wico will be redesignated as non-independent chairman. Despite the decline in profitability, the remuneration for key management personnel remained consistent, with a stable bonus component, raising questions about the alignment with the company’s pay-for-performance principle. The board is also focusing on renewal and succession plans, with a new Lead Independent Director to be appointed and changes in the composition of board committees.
Environmental Concerns
Vicplas reported an increase in greenhouse gas emissions intensity in FY2024, attributed to the decline in revenue and expansion of manufacturing facilities. The group is committed to improving manufacturing processes to reduce emissions and enhance resource efficiency.
Shareholder Returns
The total shareholder return over the past 16 years was 113%, 94% over 10 years, and 61% over five years. The company underscores the inauguration of dividend payments in 2010 as a significant milestone under Mr. Yeo Wico’s leadership.
These developments, particularly the financial losses, leadership changes, and geopolitical risks, could potentially influence the company’s share price and are critical for current and prospective investors to consider.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Readers should conduct their own research or consult a financial advisor before making investment decisions.
View Vicplas Intl Historical chart here
